Cargando…

Structural Basis for Differential Neutralization of Ebolaviruses

There are five antigenically distinct ebolaviruses that cause hemorrhagic fever in humans or non-human primates (Ebola virus, Sudan virus, Reston virus, Taï Forest virus, and Bundibugyo virus). The small handful of antibodies known to neutralize the ebolaviruses bind to the surface glycoprotein term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bale, Shridhar, Dias, Joao M., Fusco, Marnie L., Hashiguchi, Takao, Wong, Anthony C., Liu, Tong, Keuhne, Ana I., Li, Sheng, Woods, Virgil L., Chandran, Kartik, Dye, John M., Saphire, Erica Ollmann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347318/ https://www.ncbi.nlm.nih.gov/pubmed/22590681 http://dx.doi.org/10.3390/v4040447

Ejemplares similares

A Shared Structural Solution for Neutralizing Ebolaviruses
por: Dias, João M., et al.
Publicado: (2011)

Structural Basis of Broad Ebolavirus Neutralization by a Human Survivor Antibody
por: West, Brandyn R., et al.
Publicado: (2019)

Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope
por: West, Brandyn R., et al.
Publicado: (2018)

Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies
por: Bornholdt, Zachary A., et al.
Publicado: (2016)

Ebola Virus Glycoprotein Needs an Additional Trigger, beyond Proteolytic Priming for Membrane Fusion
por: Bale, Shridhar, et al.
Publicado: (2011)

133 Structural basis for ebolavirus matrix assembly and budding; protein plasticity allows multiple functions
por: Bornholdt, Zachary, et al.
Publicado: (2014)

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
por: King, Liam B., et al.
Publicado: (2019)

Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
por: Gilchuk, Pavlo, et al.
Publicado: (2018)

Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses
por: Hastie, Kathryn M, et al.
Publicado: (2012)

Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus
por: Howell, Katie A., et al.
Publicado: (2017)

Structure of the Reston ebolavirus VP30 C-terminal domain
por: Clifton, Matthew C., et al.
Publicado: (2014)

Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment
por: Landeras-Bueno, Sara, et al.
Publicado: (2019)

Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors
por: Bramble, Matthew S, et al.
Publicado: (2018)

Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
por: Gilchuk, Pavlo, et al.
Publicado: (2020)

Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
por: Janus, Benjamin M., et al.
Publicado: (2018)

Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
por: Gilchuk, Pavlo, et al.
Publicado: (2021)

Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
por: Chen, Elaine C., et al.
Publicado: (2023)

Glycan shield of the ebolavirus envelope glycoprotein GP
por: Peng, Weiwei, et al.
Publicado: (2022)

Niemann-Pick C1 Is Essential for Ebolavirus Replication and Pathogenesis In Vivo
por: Herbert, Andrew S., et al.
Publicado: (2015)

Structural Basis for the dsRNA Specificity of the Lassa Virus NP Exonuclease
por: Hastie, Kathryn M., et al.
Publicado: (2012)

Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein
por: Olal, Daniel, et al.
Publicado: (2014)

Synthetic Antibodies with a Human Framework That Protect Mice from Lethal Sudan Ebolavirus Challenge
por: Chen, Gang, et al.
Publicado: (2014)

Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the Congo
por: Shaffer, Kelly C. L., et al.
Publicado: (2022)

Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development
por: Murin, Charles D., et al.
Publicado: (2022)

The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold
por: Zhang, Adrianna P. P., et al.
Publicado: (2012)

Correction: The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold
por: Zhang, Adrianna P. P., et al.
Publicado: (2013)

Novel attempts launched toward universal Sarbecovirus vaccine
por: Li, Haoyang, et al.
Publicado: (2021)

Development and Structural Analysis of Antibody Therapeutics for Filoviruses
por: Yu, Xiaoying, et al.
Publicado: (2022)

Ebolavirus Database: Gene and Protein Information Resource for Ebolaviruses
por: Swetha, Rayapadi G., et al.
Publicado: (2016)

Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats
por: Ng, Melinda, et al.
Publicado: (2015)

Lassa virus glycoprotein: stopping a moving target
por: Hastie, Kathryn M, et al.
Publicado: (2018)

Lifted Up from Lockdown
por: Arturo, Emilia C., et al.
Publicado: (2020)

Small molecule inhibitors reveal Niemann-Pick C1 is essential for ebolavirus infection
por: Côté, Marceline, et al.
Publicado: (2011)

Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody
por: Callaway, Heather M., et al.
Publicado: (2022)

Assembly and Budding of Ebolavirus
por: Noda, Takeshi, et al.
Publicado: (2006)

Ebolavirus comparative genomics
por: Jun, Se-Ran, et al.
Publicado: (2015)

Ebolavirus and Other Filoviruses
por: Leroy, E., et al.
Publicado: (2007)

Plasmodium infection disrupts the T follicular helper cell response to heterologous immunization
por: Fontana, Mary F, et al.
Publicado: (2023)

Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
por: Murin, Charles D., et al.
Publicado: (2021)

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hvinj5vp4v43sqv6kcd4gp7pi8